Lieneke Fm Ariens

5PUBLICATIONS
14CO-AUTHORS
AllergyEpidemiological modellingMolecular medicinePharmaceutical delivery technologiesBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 27, 2021
Conjunctival inflammation in dupilumab-treated atopic dermatitis comprises a multicellular infiltrate with elevated T1/T17 cytokines: A case series study.

Daphne S Bakker, José J M Ter Linde, Mojtaba M Amini

|Dec 11, 2020
EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers.

Daphne S Bakker, Lieneke F M Ariens, Barbara Giovannone

|Apr 18, 2020
Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry.

Lotte S Spekhorst, Lieneke F M Ariëns, Jorien van der Schaft

|Oct 09, 2019
Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry.

Lieneke F M Ariëns, Jorien van der Schaft, Daphne S Bakker

|Sep 07, 2017
Barriers and Facilitators to eHealth Use in Daily Practice: Perspectives of Patients and Professionals in Dermatology.

Lieneke Fm Ariens, Florine Ml Schussler-Raymakers, Cynthia Frima

Pageof 1

Frequent Collaborators

5 joint publications

Marjolein S de Bruin-Weller

4 joint publications

Judith L Thijs

2 joint publications

Julia Drylewicz

2 joint publications

Daphne S Bakker